[HTML][HTML] SARS-CoV-2 RNA extraction using magnetic beads for rapid large-scale testing by RT-qPCR and RT-LAMP
…, A Freistaedter, I Ambiel, SL Winter, L Zimmermann… - Viruses, 2020 - mdpi.com
Rapid large-scale testing is essential for controlling the ongoing pandemic of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). The standard diagnostic pipeline for …
respiratory syndrome coronavirus 2 (SARS-CoV-2). The standard diagnostic pipeline for …
[HTML][HTML] SARS-CoV-2 nsp3 and nsp4 are minimal constituents of a pore spanning replication organelle
L Zimmermann, X Zhao, J Makroczyova… - Nature …, 2023 - nature.com
Coronavirus replication is associated with the remodeling of cellular membranes, resulting
in the formation of double-membrane vesicles (DMVs). A DMV-spanning pore was identified …
in the formation of double-membrane vesicles (DMVs). A DMV-spanning pore was identified …
[PDF][PDF] SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9
…, S Zielinski, H Keshishian, CA Lareau, L Zimmermann… - Cell, 2023 - cell.com
Regulation of viral RNA biogenesis is fundamental to productive SARS-CoV-2 infection. To
characterize host RNA-binding proteins (RBPs) involved in this process, we biochemically …
characterize host RNA-binding proteins (RBPs) involved in this process, we biochemically …
The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication In Vitro and Decreases Viral Titers and Disease Progression in …
Combinations of direct-acting antivirals are needed to minimize drug resistance mutations
and stably suppress replication of RNA viruses. Currently, there are limited therapeutic …
and stably suppress replication of RNA viruses. Currently, there are limited therapeutic …
Cryo-electron tomography of viral infection—from applications to biosafety
L Zimmermann, P Chlanda - Current Opinion in Virology, 2023 - Elsevier
Highlights • Whole-cell and on-lamellae cryo-ET for structural studies of viral infection. •
Inactivation protocols for improved structural preservation and biosafety. • VLP and replicon …
Inactivation protocols for improved structural preservation and biosafety. • VLP and replicon …
SARS-CoV-2 nsp3-4 suffice to form a pore shaping replication organelles
L Zimmermann, X Zhao, J Makroczyova… - bioRxiv, 2022 - biorxiv.org
Coronavirus replication is associated with the remodeling of cellular membranes resulting
in the formation of double-membrane vesicles (DMVs). Recently, a pore spanning DMV was …
in the formation of double-membrane vesicles (DMVs). Recently, a pore spanning DMV was …
The role of heparin in spike SARS-CoV-2 infection: From a model for heparan sulfates to a starting structure for antivirals
G Paiardi, M Milanesi, M Ferraz, L Zimmermann… - Biophysical …, 2024 - cell.com
Diseases, Heidelberg University, Heidelberg, Germany, 6Glycores 2000 Srl, Milan, Italy,
7Department of Microbiology and Virology, Spedali Civili, Brescia, Italy, 8Faculty of Biosciences, …
7Department of Microbiology and Virology, Spedali Civili, Brescia, Italy, 8Faculty of Biosciences, …
An Environmental Restriction impairs HIV-1 virion fusion and triggers innate immune recognition
S Sid Ahmed, L Zimmermann, A Imle, K Wuebben… - bioRxiv, 2023 - biorxiv.org
In vivo, HIV-1 replicates within 3D tissues, yet the impact of tissue-like environments on viral
spread is largely unknown. Our previous research identified that synthetic 3D environments …
spread is largely unknown. Our previous research identified that synthetic 3D environments …
Elevated miR‐122 serum levels are an independent marker of liver injury in inflammatory diseases
…, K Kreggenwinkel, HW Zimmermann… - Liver …, 2015 - Wiley Online Library
Background & Aims Serum concentrations of miR‐122 were proposed as a marker for various
inflammatory diseases, but the mechanisms driving alterations in miR‐122 serum levels …
inflammatory diseases, but the mechanisms driving alterations in miR‐122 serum levels …
The FDA-approved drug cobicistat synergizes with remdesivir to inhibit SARS-CoV-2 replication (preprint)
Combinations of direct-acting antivirals are needed to minimize drug-resistance mutations
and stably suppress replication of RNA viruses. Currently, there are limited therapeutic …
and stably suppress replication of RNA viruses. Currently, there are limited therapeutic …